Brochure | Kidney Care | Renal health | Dialysis

Renalyx Unveils AI-Powered Indigenous Dialysis Machine To Revolutionise Renal Care

2025-06-13 - 2025-06

In a major leap for India’s medtech innovation and kidney care infrastructure, Renalyx Health Systems has launched the world’s first fully indigenous, AI-powered, cloud-enabled smart hemodialysis machine RENALYX – RxT 21. Priced at Rs 6.7 lakh, the device is significantly more affordable than imported alternatives and aims to make dialysis services more accessible and affordable, especially across semi-urban and rural India.

Designed and manufactured entirely in India, the RxT 21 leverages advanced cloud technologies and artificial intelligence to support real-time remote monitoring, integrated clinical decision-making, and telenephrology. With CE certification, Renalyx becomes the sixth company globally and the first in India to build such an advanced dialysis machine, marking a new era in indigenous health technology.

Renal care firm Renalyx to invest Rs 800 crore in Karnataka manufacturing plants

2025-06-12 - 2025-06

Bengaluru-based Renalyx Health Systems, which is into renal care, has launched what it claims to be the world’s first fully indigenous, AI and cloud-enabled smart hemodialysis machine with real-time remote monitoring and clinical connectivity facility.The company also claimed that they are the sixth in the world and the first company in the country to produce an advanced dialysis machine with EU CE

Takeda presents positive results from trial of chronic kidney disease treatment

2025-06-11 - 2025-06

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab.

The data was presented at the European Renal Association Congress on 6 June 2025 in Vienna, Austria. It indicated that at week 48, IgAN patients treated with mezagitamab experienced significant benefits compared to those who received standard-of-care therapy alone. These patients achieved rapid and sustained reductions in both serum IgA and proteinuria, as well as stable renal function. Additionally, no serious adverse side effects or discontinuations were reported.

Apex Kidney Care secures FDI worth $9 mn from Swiss Blue Earth Capital

2025-06-10 - 2025-06

India's second-largest dialysis service provider, Apex Kidney Care (AKC), has received $9 million in foreign direct investment (FDI) from Swiss investor Blue Earth Capital AG for an undisclosed equity stake. The valuation of AKC was also not disclosed. Last May, India's largest dialysis service provider, NephroPlus, was valued at around Rs 2,000 crore when Quadria Capital acquired a stake.

As for AKC, this investment was facilitated by Tata Capital Healthcare Fund, the healthcare-focused private equity fund of Tata Capital. Last year, TCHF invested an equivalent amount in AKC through a similar equity investment.

Visalakshi Chandramouli, managing partner at Tata Capital Healthcare Fund II, said: “We are pleased to partner with Blue Earth Capital, our key limited partner, to facilitate a co-investment in a TCHF portfolio company."

Vantive will invest $1B for digitally-enabled kidney care, vital organ support

2025-06-05 - 2025-06

Vantive, a company that provides vital organ therapies, announced it will invest more than $1 billion over the next five years to drive innovation of digitally-enabled therapies aimed at enhancing access to care, the patient experience and patient outcomes.

In addition, the company stated that its investment in research and development as well as manufacturing capacity is aimed at accelerating the rate of innovation.

Through the development of digitally-enabled dialysis and critical care products and services, Vantive aims to empower earlier and more informed clinical decision-making, thereby reducing disruptions to patient care.

The company also plans to shift kidney care management from an episodic to a proactive approach, with the expectation of enhancing connectivity among the patient care team

AstraZeneca’s Forxiga recommended for chronic kidney disease treatment

2025-06-03 - 2025-06

The National Institute for Health and Care Excellence (NICE) has published updated guidance recommending Forxiga (dapagliflozin) as a treatment option for chronic kidney disease (CKD) in a broader patient population.

The decision follows a review of additional clinical data, including real-world evidence and previous trial results, which demonstrated the drug’s efficacy in treating CKD.
CKD affects more than 7 million people in the UK, with 1 million unaware they have the condition. It causes up to 45,000 premature deaths each year and places a significant burden on the healthcare system.

Patient-Led Innovations Summit Points to a Bright Future for Kidney Care

2025-06-02 - 2025-06

Dr. McGroder quoted Anna Greka, MD, PhD, who has studied the molecular mechanisms underlying ADTKD, as saying, “Rare genetic diseases are collectively common.” Supporting that point, Dr. McGroder used ADTKD as an example of how research on rare diseases helps inform discovery for other diseases. She noted that insights on more than 50 disorders may be gained from ADTKD research, making investment in rare diseases critical.

Following Dr. McGroder’s segment, Daniel Jones, PhD, of Apellis discussed the role of complement activation in kidney, heart, ophthalmologic, and other diseases. Apellis developed Empaveli (pegcetacoplan), which was recently approved to treat paroxysmal nocturnal hemoglobinuria and is being investigated as a treatment for C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis, and other diseases.

DaVita commends extension of Kidney Care Choices Model

2025-05-31 - 2025-05

DENVER - DaVita (NYSE: DVA), a leading provider of kidney care services with a market capitalization of $10.3 billion, has expressed support for the recent decision by the Center for Medicare and Medicaid Innovation (CMMI) to extend its Kidney Care Choices (KCC) Model for an additional year. The announcement, attributed to Misha Palecek, DaVita’s chief transformation officer, acknowledges the company’s role as a long-standing participant in value-based care initiatives and its commitment to improving kidney care. According to InvestingPro analysis, DaVita maintains a GREAT financial health score, positioning it well for continued innovation in healthcare delivery.

The KCC Model, which focuses on patient-centered care and collaboration among healthcare providers, aims to enhance health outcomes for individuals with kidney disease. DaVita’s involvement in the program is part of its broader effort to establish new standards in kidney care through integrated care systems developed with nephrology partners.

Global Initiative Launched to Protect Kidney Patients During Crises and Emergencies

2025-05-23 - 2025-05

An international alliance of humanitarian and medical organizations is announcing the launch of a new initiative to protect kidney and dialysis patients in crisis settings around the world.

The Global Humanitarian Kidney Support Initiative—a collaboration among Direct Relief, the American Society of Nephrology (ASN), the European Renal Association (ERA), and the International Society of Nephrology (ISN)—aims to ensure continuity of care for people with serious kidney conditions during disasters, conflicts, and in regions where access to essential health services is limited.
The initiative brings together global clinical expertise in nephrology with on-the-ground experience in humanitarian logistics to help sustain kidney care when health systems are disrupted or overwhelmed.

Hear From Kidney Disease Patients Participating in a CSL Clinical Trial

2025-05-20 - 2025-05

End Stage Kidney Disease (ESKD) patients typically receive little attention from researchers. But CSL is running one of two active interventional clinical trials for ESKD, a patient population whose kidneys are so impaired that they need dialysis or a transplant.

Kidneys are essential for filtering the blood and producing urine. When someone has ESKD, their kidneys are failing. Visiting dialysis centers about three times a week significantly impacts their daily lives. Additionally, people with ESKD are at a higher risk of cardiovascular events, regardless of their age.

Watch the video above to hear from patients about the challenges they face.

CSL’s research trial involves about 2,100 patients across 34 countries and 585 research sites. This event-driven trial aims to demonstrate a clinically significant reduction in cardiovascular outcomes with the potential treatment compared to the standard of care.
More than 2.4 million ESKD patients received treatment across multiple countries, according to a 2016 estimate. Another 2019 survey reported more than 700,000 ESKD patients were treated in the United States alone.

Imaging and spatially resolved mass spectrometry applications in nephrology

2025-05-19 - 2025-05

The application of spatially resolved mass spectrometry (MS) and MS imaging approaches for studying biomolecular processes in the kidney is rapidly growing. These powerful methods, which enable label-free and multiplexed detection of many molecular classes across omics domains (including metabolites, drugs, proteins and protein post-translational modifications), are beginning to reveal new molecular insights related to kidney health and disease. The complexity of the kidney often necessitates multiple scales of analysis for interrogating biofluids, whole organs, functional tissue units, single cells and subcellular compartments. Various MS methods can generate omics data across these spatial domains and facilitate both basic science and pathological assessment of the kidney. Optimal processes related to sample preparation and handling for different MS applications are rapidly evolving. Emerging technology and methods, improvement of spatial resolution, broader molecular characterization, multimodal and multiomics approaches and the use of machine learning and artificial intelligence approaches promise to make these applications even more valuable in the field of nephology. Overall, spatially resolved MS and MS imaging methods have the potential to fill much of the omics gap in systems biology analysis of the kidney and provide functional outputs that cannot be obtained using genomics and transcriptomic methods.

Apex Kidney Care secures investment from Blue Earth Capital AG

2025-05-16 - 2025-05

Apex Kidney Care (AKC) has received $9 million in Foreign Direct Investment (FDI) from investment vehicles of Blue Earth Capital AG (BlueEarth), a Switzerland-based global impact investment firm, for an undisclosed equity stake.

This investment was facilitated by Tata Capital Healthcare Fund (TCHF), the healthcare-focused private equity fund of Tata Capital.

Speaking on the partnership, Visalakshi Chandramouli, Managing Partner, Tata Capital Healthcare Fund II said “We are pleased to partner with Blue Earth Capital, our key Limited Partner, to facilitate a co-investment in a TCHF portfolio company. This collaboration highlights our shared commitment to meeting the growing need for accessible, high-quality dialysis care in India. Co-investments remain a vital part of TCHF’s strategy, providing portfolio companies with enhanced access to growth capital and opportunities.”

Onconephrology: Innovating Kidney Care in Cancer Patients

2025-05-15 - 2025-05

A dedicated onconephrology service at Brigham and Women’s Hospital (BWH), Boston, improved acute kidney injury (AKI) recovery rates in patients treated for cancer, according to a preliminary before-and-after analysis.
Onconephrology is an emerging subspecialty focused on managing kidney complications in patients with cancer. These complications may stem from the cancer itself or from treatments such as chemotherapy, immunotherapy, or stem cell transplantation.

UC Davis Health launches new cell therapy trial for chronic kidney disease patients

2025-05-14 - 2025-05

Novel therapy could restore kidney function in some patients with renal disease due to type 2 diabetes
(SACRAMENTO)
About one in seven people in the United States suffers from chronic kidney disease (CKD), with diabetic kidney disease (DKD) being the main cause.

With CKD, the kidneys are damaged and cannot filter blood as well as they should. Because of this, excess fluid and waste from blood remain in the body and may cause additional health problems — including high blood pressure, heart disease, stroke and early death.
Existing therapies like dialysis may delay the decline of kidney function, yet many patients continue to progress to kidney failure.

Miltenyi Biotec article From Yale to healthcare leader: Dr Shika Pappoe’s impact on kidney care

2025-05-13 - 2025-05

In the ever-evolving field of STEM, individuals are continually shaping their careers through both innovation and perseverance. Dr Shika Pappoe, an advisor at Carna Health, is a leader in healthcare transformation, focused on improving kidney care, addressing systemic healthcare challenges and developing new models for chronic kidney disease (CKD). With an academic foundation from Yale and Harvard, combined with key leadership roles across healthcare organisations, Pappoe’s journey highlights the impact of blending clinical expertise with a commitment to public health. In this interview, she shares her insights on overcoming challenges, advancing patient care and driving future innovations in healthcare and STEM.

Value-based care emerged as an alternative to fee-for-service (FFS) models in primary care to reward quality over quantity by aligning provider incentives with patient outcomes in a pay-for-performance arrangement. Now value-based specialty care, includin

2025-05-12 - 2025-05

Value-based care emerged as an alternative to fee-for-service (FFS) models in primary care to reward quality over quantity by aligning provider incentives with patient outcomes in a pay-for-performance arrangement. Now value-based specialty care, including for kidney disease, is quickly catching up, and early results from the federal value-based Kidney Care Choices (KCC) model show it is already starting to pay off. This model is a bellwether for continued adoption of value-based kidney care and value-based specialty care more broadly.

City of Hope Research on Breast Cancer, Supportive Care, Kidney Cancer and More to Be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

2025-05-09 - 2025-05

LOS ANGELES--(BUSINESS WIRE)--Experts from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named a Top 5 “Best Hospital” in the nation for cancer care by U.S. News & World Report, will be among the specialists sharing the biggest oncology research data of the year at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 30-June 3 in Chicago and online.

Delhi govt instals 300 dialysis machines in 16 hospitals for free kidney care to BPL patients

2025-05-08 - 2025-05

New Delhi, May 6 (PTI) The Delhi government has installed 300 dialysis machines across 16 government hospitals to provide free and affordable kidney care for underprivileged patients.
The initiative is being implemented under the Prime Minister National Dialysis Programme (PMNDP) and the state's Public-Private Partnership (PPP) dialysis project.
Health Minister Pankaj Singh said this initiative aligns with Prime Minister Narendra Modi's vision of expanding access to life-saving treatments and Delhi Chief Minister Rekha Gupta's commitment to inclusive healthcare.
"This is a significant milestone in our journey to build a healthier Delhi. Dialysis is a life-saving service and every person in need must have access to it, regardless of their financial status," Singh said.
Of the 300 machines, 150 were already operational under the PMNDP in 10 hospitals and 150 new machines have now been added across six more hospitals. The new facilities will further enhance capacity and bring relief to hundreds of patients suffering from chronic kidney disease.

The effects of sex hormone therapy on kidney function

2025-05-07 - 2025-05

Progression of chronic kidney disease (CKD) is generally faster in cisgender men than cisgender women, suggesting a protective effect of female sex. An observational study in 44 transgender individuals who initiated either feminizing (estradiol and antiandrogens) or masculinizing (testosterone) hormone therapy provides new insights into the effects of sex hormones on the kidney. “This population provides a unique opportunity to study the effects of well-defined changes in sex hormone concentrations,” says researcher Sarah van Eeghen.

Apex Kidney Care bags $9M funding from Blue Earth Capital AG Read more at: https://yourstory.com/2025/02/apex-kidney-care-bags-9m-fdi-funding-from-blue-earth-capital-ag

2025-05-06 - 2025-05

“We are pleased to partner with Blue Earth Capital, our key Limited Partner, to facilitate a co-investment in a TCHF portfolio company. This collaboration highlights our shared commitment to meeting the growing need for accessible, high-quality dialysis care in India. Co-investments remain a vital part of TCHF’s strategy, providing portfolio companies with enhanced access to growth capital and opportunities,” said Visalakshi Chandramouli, Managing Partner, Tata Capital Healthcare Fund II.

Apex Kidney Care bags $9M funding from Blue Earth Capital AG Read more at: https://yourstory.com/2025/02/apex-kidney-care-bags-9m-fdi-funding-from-blue-earth-capital-ag

2025-05-06 - 2025-05

Sharing is caring: OSU alumna donates kidney to fiance

2025-05-03 - 2025-05

“I was shocked by the number of people reaching out to my parents and me about where to sign up to donate,” said Hare, who graduated from OSU in 2022 with a degree in sports management. “But I was more at a loss for words when I found out Alex was a match.”

Hare’s health problems began with persistent nausea and vomiting that multiple urgent care visits failed to diagnose. Despite high blood pressure readings that doctors attributed to white coat syndrome, no blood work was ordered.
“Every day, he was really sick,” Phillips said. “I said, ‘This is not normal. We need to go to the doctor.’”

Reduce kidney damage risk by cutting five common drinks from your diet

2025-05-02 - 2025-05

The contents of our daily fluid intake can significantly affect kidney health, even if we don't immediately feel the consequences. Kidneys are central in filtering waste products, balancing fluid levels and regulating electrolytes to maintain overall health. What and how much you drink can directly influence critical functions.

For instance, adequate plain water intake supports glomerular filtration, where blood is filtered in the kidneys, separating water, salts, and other small molecules from the blood into urine. Drinking too much or too little water is linked to worsened outcomes in chronic kidney diseas

Healthy.io Acquires Labrador Health, Advancing the Future of At-Home Kidney Diagnostics

2025-04-30 - 2025-04

This strategic acquisition marks a step forward in Healthy.io's mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone. By integrating Labrador Health's technology with Healthy.io's FDA-cleared and CE-marked suite of products already available globally, the company is poised to launch the next generation of quantitative at-home kidney testing, expanding access to high-quality diagnostics around the world.

The team is already collaborating on developing the first ever quantitative, home-based ACR test - expected to launch in 2026. This home test is designed to tackle the significant global care-gap in Chronic Kidney Disease. With its novel quantitative features, the product will align with existing care-pathways and international reimbursement schemes, while making testing more accessible and routine - enabling earlier detection and better outcomes at scale.

As part of the integration, all Labrador team members will be joining Healthy.io. At the same time, the company is sharpening its focus on scalable, high-impact offerings by realigning internal resources to accelerate commercialization and innovation in its core markets. This renewed focus will support continued growth of Healthy.io's existing semi-quantitative product while driving the development of next-generation diagnostics enabled by the newly acquired technology.

Delhi hospital engages with Civil Hospital on kidney, liver & cancer care

2025-04-29 - 2025-04

The experts spoke about emerging advancements in kidney, liver, & bone marrow transplant and recent advancements in cancer treatment.
The event was designed to bring together leading healthcare professionals and the media to promote knowledge-sharing and elevate clinical practices through evidence-based discussions.

Delhi-based DCDC Kidney Care raises Rs 150 crore from ABC Impact

2025-04-28 - 2025-04

Delhi-based DCDC Kidney Care has raised Rs 150 crore in funding from Singapore-based ABC Impact, an Asia-focused impact investor backed by Temasek.

The company operates more than 200 dialysis centres across India under both public-private partnerships and standalone clinics.

It plans to use the new funding to open more than 150 additional clinics in the coming months, aiming to serve the large number of patients who travel long distances—often up to 50 kilometres—to access dialysis services.

Self-care alone will not solve burnout; deeper approach to well-being key

2025-04-25 - 2025-04

“Over the past several years I started to notice that self-care was having a moment for health care workers. It was becoming so clear how burnt out social workers, nurses, doctors, everybody was feeling,” she said. “The solution was to offer us things like free yoga classes or workshops on meditation. This is lovely — I actually teach a chair yoga class to staff once a month — but it did not get to the core issue I felt we were all experiencing.”

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Franci

2025-04-24 - 2025-04

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Francisco (UCSF) and Mass General Brigham found that electronic messages sent to providers within one week of patients receiving an echocardiogram improved care for patients with severe AS - including higher rates of treatment with aortic valve replacement (AVR), particularly in symptomatic patients.
The results are published in Circulation and presented at the 2025 American College of Cardiology's Annual Scientific Session & Exp

Opinion: Global kidney health via sustainability — a ‘best buy’ approach

2025-04-24 - 2025-04

As national health systems transition to net-zero greenhouse gas emissions and climate resiliency, nephrologists collaborating with the International Society of Nephrology, or ISN, emphasize the need for a sectoral approach to develop solutions to the sustainability and resiliency challenges facing regional and global kidney care.

Opinion: Global kidney health via sustainability — a ‘best buy’ approach

2025-04-23 - 2025-04

Environmental degradation, including climate change, plays a role in the worsening burden of kidney diseases worldwide. The ISN-led Global Environmental Evolution in Nephrology and Kidney Care initiative, or GREEN-K, seeks to change that by enhancing environmentally sustainable and resilient kidney care globally. We hear from the experts.

Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment

2025-04-22 - 2025-04

After implementing an interdisciplinary care model for managing chronic kidney disease (CKD), hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30%, according to a Mayo Clinic study published in Kidney360. The reductions in acute care needs were statistically significant, supporting the benefit of the clinic's comprehensive approach in managing patients more effectively in outpatient settings.

What Is Ailing Nephrology

2025-04-21 - 2025-04

As we return from another American Society of Nephrology (ASN) meeting brimming with new knowledge and excited by the range of advances in therapies, there is no better time to be a nephrologist. So, why does nephrology remain unattractive to medical students and residents
Ten years ago, Jeff Berns and colleagues1 noted declining interest in nephrology among medical students and residents and identified an urgent need to better define the subspecialty and its scope of practice and to rethink fellowship training programs and training requirements. However, not much has changed, as an editorial by Farouk and Sparks2 points out, and the basic structures and limitations of nephrology training endure.

Bio-engineered kidney transplant offers hope for millions

2025-04-19 - 2025-04

The kidneys play a vital role in maintaining overall health by filtering waste, excess fluids, and electrolytes, such as sodium and potassium, from the blood. They also help regulate blood pressure, red blood cell production and calcium balance in the body. When the kidneys are damaged, their ability to filter waste and maintain balance is compromised, leading to a buildup of toxins, fluid retention and an imbalance in electrolytes.

This can cause a range of health problems, from high blood pressure to heart disease and weakened bones. Kidney damage can progress to chronic kidney disease and kidney failure over time.
Kidney damage, then, can affect almost part of your body – but there are simple lifestyle changes you can make today to avoid harming your kidneys tomorrow.

National Kidney Foundation marks 75 years with initiative to change care

2025-04-17 - 2025-04

One pillar to help reach that goal is early disease detection. CKD is often linked to conditions like diabetes and hypertension, Campbell said, which may be treatable if caught early. Health care professionals should look toward genetic predispositions and conditions like age, family history and race when assessing renal conditions. Proactive screening and reducing cardiovascular risks are also key in curbing kidney disease.

Physicians discuss innovating kidney care in patients with cancer

2025-04-16 - 2025-04

Onconephrology is an emerging subspecialty that involves the care of patients with cancer and kidney disease. Kidney disease can occur from the cancer itself, or from complications of cancer treatment (e.g., immunotherapy, conventional chemotherapies, stem cell transplant).
Furthermore, as patients with cancer are living longer, they are more prone to developing chronic kidney disease, which can jeopardize their eligibility for other therapies and make dosing of chemotherapy more challenging. Thus, onconephrology has become an increasingly important subspecialty.
Dr. Gupta founded the American Society of Onconephrology (ASON) and served as its first president, and Dr. Chowdhury is now the vice president of ASON. The organization has members from 14 countries around the world.

Kidney Care Choices model shows promise for future of value-based care

2025-04-14 - 2025-04

The federal value-based Kidney Care Choices model for kidney disease is now in year 4.
Result from year 1 show success for the program.
The journey toward a new sustainable, government-backed value-based model for kidney disease is now in year 4 with early results showing promise for the future.
The hope is the model can be made permanent by CMS by proving it can either improve quality and maintain costs, improve quality and reduce costs, or reduce costs and maintain quality.

Renacare Dialysis Celebrates 5th Anniversary with a Commitment to Excellence in Kidney Care

2025-04-11 - 2025-04

Noida (Uttar Pradesh) [India], April 10: Renacare Dialysis, under the visionary leadership of Dr. Anil Prasad Bhatt, is celebrating its fifth anniversary in 2025, coinciding with World Health Day on April 7th. From its humble beginnings during the COVID-19 lockdown in 2020, Renacare has rapidly transformed into one of the most trusted dialysis and nephrology services in Noida and Greater Noida. Today, the organization operates six state-of-the-art dialysis centers, including key locations such as Noida Multispeciality Hospital in Sector 66, and Mahanandan Hospital in Greater Noida, providing advanced kidney care to a growing number of patients.
Renacare has garnered widespread acclaim for the quality of services it offers, as reflected in positive Google reviews and social media feedback from patients.

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

2025-04-10 - 2025-04

DCDC Health Services, which operates dialysis centres under the DCDC Kidney Care brand, announced that it has secured an investment of Rs 150 crore from Singapore-based ABC Impact, an Asia-focused impact investor backed by Temasek.

DCDC Health currently operates more than 200 centres across India under the public-private partnerships (PPP) mode. There are company-owned standalone clinics, serving more than 20,000 patients annually.
The investment from ABC aims to support DCDC’s expansion plans, facilitating the rollout of over 150 new clinics across the country in the coming months.
Commenting on the development, DCDC founder and CEO Aseem Garg said the company is also planning to extend its solutions to countries beyond India.

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

2025-04-09 - 2025-04

Outstanding Kidney Care Professionals to Be Honored at NKF SCM25

2025-04-04 - 2025-04

Bradley A. Warady, MD, is this year’s recipient of the David M. Hume Memorial Award, the highest honor given to a distinguished scientist-clinician in the field of kidney and urologic diseases. Dr. Warady is the McLaughlin Family Endowed Chair in Nephrology and a professor of pediatrics at the University of Missouri–Kansas City School of Medicine and serves as the director of the nephrology division and director of dialysis and transplantation at Children’s Mercy Kansas City. He focuses on pediatric chronic kidney disease (CKD) and end-stage renal disease, with an academic emphasis on collaborative research.

AKF and MAVEN Project Join Forces on Educational Kidney Care Initiative

2025-04-02 - 2025-04

The American Kidney Fund (AKF) and MAVEN Project will partner to support primary care clinicians with educational resources to strengthen early identification and treatment of kidney disease.
MAVEN Project is a nonprofit with a mission to address inequities in healthcare by connecting providers at safety net clinics with expert physician volunteers. AKF is a nonprofit supporting kidney health through programs that address early detection, disease management, financial assistance, clinical research, innovation, and advocacy.
Under the partnership, AKF will develop content for an educational activity for community health centers and safety net clinics and provide subject matter expertise for subsequent educational activities when possible. MAVEN Project will provide continuing medical education accreditation to healthcare professionals for

World Kidney Day: Raising Awareness on Kidney Health at Manipal Hospital Millers Road

2025-04-02 - 2025-04

Kidney disease is often silent, with symptoms appearing only when 80-90% of kidney function is lost. Dr. Satish Kumar M. M stated, "The earliest sign of kidney disease is swelling in the legs after a longer duration of immobility due to sitting or traveling for 4-5 hours. Another red flag is early morning facial puffiness. Many also experience frequent urination at night (nocturia), indicating kidney issues. Other complaints like nausea, vomiting, and breathing difficulty only appear when kidney damage reaches an irreversible stage. Thus, the only way to pick up kidney disease early, especially in diabetes and hypertension patients, is through routine blood and urine tests to check for albumin presence and creatinine levels. We also recommend yearly eye check-ups for diabetic retinopathy, as eye damage often precedes kidney

A calculated look at semaglutide’s new role in kidney care

2025-03-31 - 2025-03

Recently, the U.S. Food and Drug Administration (FDA) approved Ozempic® (active ingredient semaglutide) as the only GLP-1 receptor agonist to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
We sat down with Ryan Singerman, DO, PPG - Family Medicine and Internal Medicine, to gain a deeper understanding of what this new indication means in practice and how the numbers behind it translate to real-world impact for individuals living with these comorbidities.

Chronic Kidney Disease Often Goes Undiagnosed, But Early Detection Can Prevent Severe Outcomes

2025-03-31 - 2025-03

For a disease afflicting 35.5 million people in the US, chronic kidney disease flies under the radar. Only half the people who have it are formally diagnosed.
The consequences of advanced chronic kidney disease are severe. When these essential organs can no longer do their job of filtering waste products from the blood, patients need intensive medical interventions that gravely diminish their quality of life.
As an assistant professor of nursing and an expert in population health, I study strategies for improving patients’ awareness of chronic kidney disease. My research shows that patients with early-stage chronic kidney disease are not getting timely information from their health care providers about how to prevent the condition from worsening.
Here’s what you need to know to keep your kidneys healthy:

Surge in the kidney disease

2025-03-28 - 2025-03

HYDERABAD: The doctors at the nephrology department of Nizam's Institute of Medical Sciences (NIMS) have observed a significant rise in kidney-related problems over the past five years. On average, NIMS treats 500 new patients each month at its nephrology centre.
Between Dec 2024 and Feb 2025, the hospital saw an intake of 19,753 outpatient visits due to kidney issues. Additionally, 2,948 individuals were treated as in-patients during the same period.

Yokohama to Host WCN’26: The World Congress of Nephrology Returns to Japan After 36 Years

2025-03-27 - 2025-03

YOKOHAMA, Japan--(BUSINESS WIRE)--The World Congress of Nephrology 2026 (WCN’26), the flagship event of the International Society of Nephrology (ISN), is set to take place in Yokohama from March 28 to 31, 2026. The Congress is co-hosted by the Japanese Society of Nephrology (JSN) and the Asian Pacific Society of Nephrology (APSN).

The Yokohama City Visitors Bureau (YCVB) and PACIFICO Yokohama, in collaboration with the City of Yokohama, supported the bid led by Professor Masaomi Nangaku, President of the Japanese Society of Nephrology. Thanks to PACIFICO Yokohama’s excellent track record in hosting international conferences and the venue’s excellent accessibility, the bid was successfully secured.

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

2025-03-26 - 2025-03

Webinar on Kidneycare

Brochure Form

Renalyx Unveils AI-Powered Indigenous Dialysis Machine To Revolutionise Renal Care

Renal care firm Renalyx to invest Rs 800 crore in Karnataka manufacturing plants

Takeda presents positive results from trial of chronic kidney disease treatment

Apex Kidney Care secures FDI worth $9 mn from Swiss Blue Earth Capital

Vantive will invest $1B for digitally-enabled kidney care, vital organ support

AstraZeneca’s Forxiga recommended for chronic kidney disease treatment

Patient-Led Innovations Summit Points to a Bright Future for Kidney Care

DaVita commends extension of Kidney Care Choices Model

Global Initiative Launched to Protect Kidney Patients During Crises and Emergencies

Hear From Kidney Disease Patients Participating in a CSL Clinical Trial

Imaging and spatially resolved mass spectrometry applications in nephrology

Apex Kidney Care secures investment from Blue Earth Capital AG

Onconephrology: Innovating Kidney Care in Cancer Patients

UC Davis Health launches new cell therapy trial for chronic kidney disease patients

Miltenyi Biotec article From Yale to healthcare leader: Dr Shika Pappoe’s impact on kidney care

Value-based care emerged as an alternative to fee-for-service (FFS) models in primary care to reward quality over quantity by aligning provider incentives with patient outcomes in a pay-for-performance arrangement. Now value-based specialty care, includin

City of Hope Research on Breast Cancer, Supportive Care, Kidney Cancer and More to Be Presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Delhi govt instals 300 dialysis machines in 16 hospitals for free kidney care to BPL patients

The effects of sex hormone therapy on kidney function

Apex Kidney Care bags $9M funding from Blue Earth Capital AG Read more at: https://yourstory.com/2025/02/apex-kidney-care-bags-9m-fdi-funding-from-blue-earth-capital-ag

Apex Kidney Care bags $9M funding from Blue Earth Capital AG Read more at: https://yourstory.com/2025/02/apex-kidney-care-bags-9m-fdi-funding-from-blue-earth-capital-ag

Sharing is caring: OSU alumna donates kidney to fiance

Reduce kidney damage risk by cutting five common drinks from your diet

Healthy.io Acquires Labrador Health, Advancing the Future of At-Home Kidney Diagnostics

Delhi hospital engages with Civil Hospital on kidney, liver & cancer care

Delhi-based DCDC Kidney Care raises Rs 150 crore from ABC Impact

Self-care alone will not solve burnout; deeper approach to well-being key

A new method of alerting clinical care providers holds promise for increasing treatment and improving survival for patients with severe aortic stenosis (AS), a valvular heart condition that can be deadly when left untreated. Researchers from UC San Franci

Opinion: Global kidney health via sustainability — a ‘best buy’ approach

Opinion: Global kidney health via sustainability — a ‘best buy’ approach

Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment

What Is Ailing Nephrology

Bio-engineered kidney transplant offers hope for millions

National Kidney Foundation marks 75 years with initiative to change care

Physicians discuss innovating kidney care in patients with cancer

Kidney Care Choices model shows promise for future of value-based care

Renacare Dialysis Celebrates 5th Anniversary with a Commitment to Excellence in Kidney Care

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

Outstanding Kidney Care Professionals to Be Honored at NKF SCM25

AKF and MAVEN Project Join Forces on Educational Kidney Care Initiative

World Kidney Day: Raising Awareness on Kidney Health at Manipal Hospital Millers Road

A calculated look at semaglutide’s new role in kidney care

Chronic Kidney Disease Often Goes Undiagnosed, But Early Detection Can Prevent Severe Outcomes

Surge in the kidney disease

Yokohama to Host WCN’26: The World Congress of Nephrology Returns to Japan After 36 Years

DCDC Kidney Care receives Rs 150 crore investment from ABC Impact

kidneycare@confmeets.net

support@confmeets.net

+44-7477-467410